SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: admr who wrote (1334)7/21/1998 8:46:00 PM
From: Joe  Read Replies (2) of 4140
 
admr... Your posts on the VISX thread
were duly noted on this thread. I commented that what you said on the Visx thread was similar to what Dr. MacFarland, an ophthalmologist from Arkansas, and an SNRS Board Member, said at the shareholder's meeting recently regarding the use of PRK and LASIK for hyperopia. It is not used much anymore outside the U.S. because of the poor results they are getting. MacFarland made this comment in response to my question about the affect on SNRS when the Opthalmic Panel recommends approval for PRK & LASIK in hyperopia next week.

When we have the opportunity to educate people like Lachman with Dow Jones about LTK, we should try to do so. If you could be more specific about the publication, maybe we could email him with some info about LTK.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext